TRAVERE THERAPEUTICS INC shareholders Q3 2023

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 174 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.

TRAVERE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ROYCE & ASSOCIATES LP 18,339$163,9510.00%
Nuveen Asset Management, LLC 705,303$6,305,4080.00%
Tower Research Capital LLC (TRC) 7,929$70,8860.00%
Cutler Group LLC / CA 2,700$240.00%
BARCLAYS PLC 288,654$2,5790.00%
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 55,806$499,0000.00%
FEDERATED HERMES, INC. 97,491$871,5700.00%
NEW YORK LIFE INVESTMENT MANAGEMENT LLC 15,831$141,5290.00%
AMERICAN INTERNATIONAL GROUP, INC. 36,356$325,0230.00%
METROPOLITAN LIFE INSURANCE CO/NY 4,440$39,6940.00%
Russell Investments Group, Ltd. 97,513$871,7650.00%
GEODE CAPITAL MANAGEMENT, LLC 1,440,644$12,880,9450.00%
STATE STREET CORP 4,395,257$39,293,5980.00%
WOLVERINE ASSET MANAGEMENT LLC 17,300$154,6620.00%
DEUTSCHE BANK AG\ 308,456$2,757,5970.00%
CITIGROUP INC 333,371$2,980,3370.00%
STATE OF WISCONSIN INVESTMENT BOARD 54,363$486,0050.00%
MORGAN STANLEY 2,240,337$20,028,6130.00%
Invesco Ltd. 813,252$7,270,4730.00%
BlackRock Inc. 7,633,205$68,240,8530.00%
External links

This page lists TRAVERE THERAPEUTICS INC's shareholders in Q3 2023. To view TRAVERE THERAPEUTICS INC's shareholder history, click here.